Nasopharyngeal Carcinoma

An induction-concurrent chemotherapy sequence conferred a PFS benefit for patients with locoregionally advanced nasopharyngeal carcinoma treated with conventional fractionated radiotherapy, according to study results published in Cancer.

Radiotherapy in combination with chemotherapy significantly improved OS among chemotherapy-sensitive patients with metastatic nasopharyngeal carcinoma, according to results of a randomized phase 3 study published in JAMA Oncology.